Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and zinquin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with zinquin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(zinquin)		Trials
(zinquin)		Recent Studies (post-2010) (zinquin)
9,15618755257010

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bode, G; Kerkhoff, C; Manitz, MP; Mooren, FC; Nacken, W; Sorg, C1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and zinquin

ArticleYear
S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils.
    The international journal of biochemistry & cell biology, 2005, Volume: 37, Issue:6

    Topics: Adenosine Triphosphate; Animals; Blotting, Western; Calcium; Calcium Signaling; Calgranulin A; Calgranulin B; Cell Adhesion; Chemokine CCL3; Chemokine CCL4; Electrophoresis, Polyacrylamide Gel; Homeostasis; Hydroxylamines; Macrophage Inflammatory Proteins; Mice; Mice, Knockout; Neutrophils; Platelet Activating Factor; Pyridines; Quinolones; Respiratory Burst; Thiones; Tosyl Compounds; Zinc

2005